Abstract:Uncontrolled inflammation contributes to the pathogenesis of numerous diseases. Scavenging of reactive oxygen species (ROS) is promising for treatment of inflammatory diseases. To circumvent current limitations, in article number 1800781, Jianxiang Zhang and co-workers report a material with broad-spectrum ROS-eliminating capability. A nanotherapy derived from this bioactive material shows superior efficacies in different mouse models of inflammation and oxidative stress injury.

Correction to "Reactive Oxygen Species-Responsive Dual Anti-Inflammatory and Antioxidative Nanoparticles for Anterior Uveitis"

Correction to "Janus ACSP Nanoparticle for Synergistic Chemodynamic Therapy and Radiosensitization"

Correction: Ocular biocompatibility evaluation of POSS nanomaterials for biomedical material applications

Correction to "Oxytocin Nanogels Inhibit Innate Inflammatory Response for Early Intervention in Alzheimer's Disease"

Correction to "Light-Activable On-Demand Release of Nano-Antibiotic Platforms for Precise Synergy of Thermochemotherapy on Periodontitis"

Correction to "Self-Stimulated Photodynamic Nanoreactor in Combination with CXCR4 Antagonists for Antileukemia Therapy''

Correction to "Targeted Chemo-Photodynamic Combination Platform Based on the DOX Prodrug Nanoparticles for Enhanced Cancer Therapy"

Reactive Oxygen Species‐Responsive Polymeric Prodrug Nanoparticles for Selective and Effective Treatment of Inflammatory Diseases (Adv. Healthcare Mater. 29/2023)

Correction: Reactive oxygen nanobiocatalysts: activity-mechanism disclosures, catalytic center evolutions, and changing states

Correction: A miRNA stabilizing polydopamine nano-platform for intraocular delivery of miR-21-5p in glaucoma therapy

Nanoparticles: A Broad‐Spectrum ROS‐Eliminating Material for Prevention of Inflammation and Drug‐Induced Organ Toxicity (adv. Sci. 10/2018)

Correction: CuCo2S4 nanocrystals as a nanoplatform for photothermal therapy of arterial inflammation.

Correction: Single Laser Activated Photothermal/photodynamic Dual-Modal Cancer Phototherapy by Using ROS-responsive Targeting Flower-Like Ruthenium Nanoparticles

Corrigendum to “Nanoenzyme engineered neutrophil-derived exosomes attenuate joint injury in advanced rheumatoid arthritis via regulating inflammatory environment” [Bioact. Mater. 18C (2022) 1–14]

Correction: Xu et al. Use of Optical Redox Imaging to Quantify Alveolar Macrophage Redox State in Infants: Proof of Concept Experiments in a Murine Model and Human Tracheal Aspirates Samples. Antioxidants 2024, 13, 546

Correction: Surface modification of intraocular lenses with hyaluronic acid and lysozyme for the prevention of endophthalmitis and posterior capsule opacification

Corrigendum: Evaluation of the Effectiveness of a Chronic Ocular Hypertension Mouse Model Induced by Intracameral Injection of Cross-Linking Hydrogel

Erratum to "Pt-Se Hybrid Nanozymes with Potent Catalytic Activities to Scavenge ROS/RONS and Regulate Macrophage Polarization for Osteoarthritis Therapy"

Correction: Feng et al. Photobiomodulation Inhibits Ischemia-Induced Brain Endothelial Senescence via Endothelial Nitric Oxide Synthase. Antioxidants 2024, 13, 633

Correction: Highly Efficient Dual-State Emission and Two-Photon Absorption of Novel Naphthalimide Functionalized Cyanostilbene Derivatives with Finely Tuned Terminal Alkoxyl Groups

Correction to "Co-Delivery of Astaxanthin and si TGF-β 1 via Ionizable Liposome Nanoparticles for Improved Idiopathic Pulmonary Fibrosis Therapy"